Filing Flows › Nexgel (NXGL) › R&D spending
Nexgel (NXGL) R&D spending by quarter
Nexgel's R&D spending was $20K in Q2 2026 (second quarter 2026), +186% from Q3 2025. Over the last 3 quarters it ranged from $1K (Q1 2025) to $20K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $20K | +186% | — |
| Q3 2025 | $7K | +600% | — |
| Q1 2025 | $1K | — | — |
Q2 2026 at a glance
Nexgel, Q2 2026: revenue $3.7M (+28% year over year), operating margin -68.0%, net loss $3.6M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Nexgel's R&D spending?
Nexgel's R&D spending was $20K in Q2 2026 (second quarter 2026), +186% from Q3 2025.
How has Nexgel's R&D spending changed?
Over the last 3 quarters it ranged from $1K (Q1 2025) to $20K (Q2 2026).